Log in
Enquire now
PostEra

PostEra

PostEra is a biotechnology company that uses machine learning for medicinal chemistry services.

OverviewStructured DataIssuesContributors

Contents

Funding Pre-seed SeedTimelineTable: Funding RoundsTable: ProductsTable: AcquisitionsTable: SBIR/STTR AwardsTable: PatentsTable: Further ResourcesReferences
postera.ai
covid.postera.ai
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Machine learning
Machine learning
Pharmaceutical industry
Pharmaceutical industry
Drug discovery
Drug discovery
Drug development
Drug development
Predictive analytics
Predictive analytics
Software
Software
Loading...
Biomedical engineering
Biomedical engineering
...
Location
Boston
Boston
San Francisco
San Francisco
Santa Clara, California
Santa Clara, California
B2X
B2C
B2C
CEO
Aaron Morris
Aaron Morris
3
Founder
Matt Robinson
Matt Robinson
2
Aaron Morris
Aaron Morris
2
Byterat
Byterat
Matthew Robinson
Matthew Robinson
Pitchbook URL
pitchbook.com/profiles...433412-65
Accelerator
Y Combinator
Y Combinator
2
Accelerator Batch
Y Combinator W20 Batch
Y Combinator W20 Batch
2
Spun Out From
University of Cambridge Enterprise
University of Cambridge Enterprise
Number of Employees (Ranges)
1 – 10
Email Address
hello@postera.ai
Full Address
9th Floor, 107 Cheapside London EC2V 6DN England, United Kingdom
Investors
ACE & Company
ACE & Company
4
I2BF Global Ventures
I2BF Global Ventures
LifeForce Capital
LifeForce Capital
Breyer Capital
Breyer Capital
HOF Capital
HOF Capital
Y Combinator
Y Combinator
2
Pioneer Fund
Pioneer Fund
Founded Date
2019
2
Total Funding Amount (USD)
26,450,000
Latest Funding Round Date
January 11, 2022
Latest Funding Type
Series A
Series A
Country
United States
United States

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
24,000,000
Y Combinator URL
ycombinator.com/compani.../postera2

PostEra is a biotechnology company using machine learning for medicinal chemistry services that is headquartered in Santa Clara, California and was founded in 2019 by Aaron Morris, Alpha Lee, and Matt Robinson. The company's machine learning algorithms can help design and optimize chemical compounds by exploring new chemical possibilities and optimizing existing scaffolds. PostEra Claims their software tools were the first to beat humans at chemical reaction prediction. Customers of PostEra are able to use their platform to order new chemical compounds.

PostEra has published scientific studies in collaboration with Pfizer to predict bioactivity with low-data limits to improve the performance of prospective experiments by two fold. Another collaborative study with Pfizer showed that PostEra's prediction algorithms are generalizable to the pharmaceutical chemical industry and can predict synthetic pathways to create drug-like molecules.

Funding
Pre-seed

On March 16, 2020 PostEra announced raising $150,000 in pre-seed funding from Y Combinator.

Seed

On March 30, 2020 PostEra announced raising $2.3 million in seed funding from undisclosed investors.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

https://discuss.postera.ai/uploads/short-url/sl2LuliKPOQGcvjf2F

References

Find more companies like PostEra

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.